Paychex, Inc. (PAYX - Free Report) is scheduled to report first-quarter fiscal 2020 results on Oct 2, before market open.
So far this year, shares of Paychex have gained 26.8% compared with 25% rise of the industry it belongs to and 17.8% increase of the Zacks S&P 500 composite.
Let's check out how things are shaping up for the announcement.
What to Expect
Paychex’s top line should benefit from strength across total service revenues and interest on funds held for clients. The Zacks Consensus Estimate for first-quarter fiscal 2020 revenues stands at $990.93 million, indicating an increase of 14.9% year over year. In fourth-quarter fiscal 2019, total revenues of $980.4 million increased 16% year over year.
Within total service, Management Solutions revenues are likely to be driven by increase in the company’s client base across many of its services and growth in revenue per check (on the back of price increases and net of discounts). Growth in clients and client worksite employees and rise in the number of health, benefit clients and applicants should boost its PEO and insurance services revenues.
Interest on funds held by clients is likely to benefit from higher average interest rates earned.
The Zacks Consensus Estimate for earnings per share in the to-be-reported quarter is pegged at 69 cents, indicating growth of 2.9% from the year-ago reported figure. In fourth-quarter fiscal 2019, adjusted earnings of 63 cents per share increased 9% year over year.
What Our Model Says
According to the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has a good chance of beating estimates if it also has a positive Earnings ESP. Zacks Rank #4 (Sell) or 5 (Strong Sell) stocks are best avoided, especially when the company is seeing negative estimate revisions. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter.
Paychex has an Earnings ESP of -0.88% and a Zacks Rank #3, a combination that makes surprise prediction difficult.
Stocks to Consider
Here are a few stocks from the broader Zacks Business Services sector that investors may consider as our model shows that these have the right combination of elements to beat estimates.
S&P Global (SPGI - Free Report) has an Earnings ESP of +0.17% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
FLEETCOR Technologies (FLT - Free Report) has an Earnings ESP of +1.38% and a Zacks Rank #3.
FactSet (FDS - Free Report) has an Earnings ESP of +0.57% and a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>